The Asia Pacific Neurovascular Catheters Market would witness market growth of 7.3% CAGR during the forecast period (2023-2029).
Minimally invasive surgeries have become increasingly popular due to their ability to minimize risk and trauma compared to traditional surgical procedures. Hemorrhages, commonly known as strokes, occur due to impaired, obstructed, or wounded blood vessels that can lead to cerebral bleeding or circulation issues. Minimally invasive surgical methods are utilized in the treatment of cerebral blood vessel blockages. Minimally invasive endovascular surgery techniques are the preferred method for removing brain blockages in the field of business.
Minimally invasive techniques utilizing neurovascular catheters and other advanced devices are the preferred method for treating stroke, aneurysm, and other blood vessel conditions in the brain. This innovative technique provides a faster recovery time and reduces physical strain on the body in comparison to traditional open surgery.
In addition, minimally invasive neurovascular surgeries result in fewer disruptions to musculoskeletal structures, thereby enhancing the procedure's efficiency and reducing patient discomfort. The catheters offer various benefits, such as minimal invasion, easy access to intracranial space, and simplifying complex procedures due to advanced designs and features. These benefits make wound closure easier and enable faster healing compared to traditional open surgery.
The rising prevalence of neurological disorders due to the ageing population is becoming a significant concern for the sustainability of healthcare systems globally, particularly in low and middle-income countries. India is likely to experience a rise in the prevalence of neurological disorders owing to the swift epidemiological and demographic transition underway in the country. The percentage of non-communicable neurological disorders in India's total DALYs has increased from 4.0% in 1990 to 8.2% in 2019. The growing prevalence of neurological diseases is expected to increase the demand for neurovascular catheters for the treatment of such diseases. Moreover, the rising R&D and the advancement of these catheters are expected to increase their adoption further, boosting the market growth in the region.
The China market dominated the Asia Pacific Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $339 million by 2029. The Japan market is estimated to grow at a CAGR of 6.6% during (2023 - 2029). Additionally, The India market would register a CAGR of 7.9% during (2023 - 2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Neurovascular Catheters Market is Projected to reach USD 4.6 Billion by 2029, at a CAGR of 6.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
By Type
By End Use
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 